Methotrexate acts as a folate antagonist by inhibiting dihydrofolate reductase for immunological support. This process prevents the synthesis of DNA and cellular replication, effectively assisting in the management of systemic autoimmune responses.
Methotrexate belongs to the class of antimetabolite drugs that interfere with cell growth. It is the active compound in several approved medicines used for immune-mediated and oncologic conditions. In Singapore, methotrexate appears on the Health Sciences Authority (HSA) registry as a widely prescribed medication for specific disease groups.
The compound is available in oral tablets, as well as in injectable forms for deeper tissue targeting. Both generic versions and brand-named preparations carry the same active ingredient, differing mainly in packaging and dose strength. Patients in Singapore may receive methotrexate tablets ranging from 2 mg to 25 mg, while the injectable form is commonly supplied in pre-filled syringes.
These applications reflect the drug’s ability to modulate immune activity and hinder rapid cell division.
Methotrexate blocks an enzyme needed for folate metabolism, which reduces the production of DNA and RNA in rapidly dividing cells. By limiting this pathway, the medication lessens the activity of over-active immune cells and slows the growth of certain tumour cells. The effect is gradual, often requiring several weeks before noticeable improvement.
Mild nausea, temporary loss of appetite, and occasional fatigue are reported by many users. Small skin rashes or mild hair thinning may also occur during the first few weeks of therapy.
Signs that require prompt medical attention include sudden shortness of breath, unexplained fever, severe abdominal pain, or yellowing of the skin or eyes. These may indicate rare but significant complications.
Pregnant individuals, people with known liver disease, or those with a history of severe allergic reactions should avoid methotrexate unless a specialist determines the benefits outweigh the risks. Regular monitoring of liver function and blood counts is standard practice.
Alcohol consumption can intensify liver-related side effects. Concurrent use of non-steroidal anti-inflammatory drugs (NSAIDs) or certain antibiotics may increase toxicity. Detailed interaction tables are provided on the specific medication pages for methotrexate.
Store tablets in a cool, dry place away from direct sunlight; injectable vials should be kept at room temperature and protected from freezing. Short-term courses for acute disease flares differ from long-term management of chronic conditions; the duration is guided by the individual medication’s label. For precise dosing and administration instructions, refer to the product’s clinical information.
This overview provides educational information about methotrexate as an active substance and does not constitute medical advice. Individual medicines containing this compound may vary in strength, formulation, and usage directions. The author assumes no responsibility for clinical decisions based on this content. Patients should refer to the labeling of their specific medication and seek guidance from a healthcare professional.
